Browsing Harvard Medical School by Keyword "Arsenic trioxide resistance"
Now showing items 1-1 of 1
-
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
(BioMed Central, 2014)Background: Arsenic trioxide has been demonstrated as an effective anti-cancer drug against leukemia and solid tumors both in vitro and in vivo. However, recent phase II trials demonstrated that single agent arsenic trioxide ...